Emmanouilidou Evangelia, Vekrellis Kostas
Department of Neuroscience, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Brain Pathol. 2016 May;26(3):398-403. doi: 10.1111/bpa.12373.
It is now established that α-synuclein can be physiologically secreted to the extracellular space. In this sense, mechanisms that govern the secretion of the protein may be of importance in the initiation and progress of synucleinopathies. It is possible that increased secretion may aid the formation of toxic seeds extracellularly. Alternatively, reduced presence of extracellular α-synuclein due to impaired secretion may increase the intracellular load and trigger intracellular seeding. Once outside, α-synuclein can exert various paracrine actions on neighboring cells again by mechanisms that have not been fully elucidated. It has been demonstrated that, when applied extracellularly, α-synuclein species can induce multiple neurotoxic and inflammatory responses, and aid the transmission of pathology between neurons. Still, the exact mechanism(s) by which secreted α-synuclein affects the homeostasis of other neurons is still not well understood. A portion of α-synuclein has been shown to be associated with the surface and lumen of exosomes which can transfer it to the surrounding cells, and potentially trigger seeding. Interestingly, increased exosome release has been linked to pathological situations of lysosomal dysfunction as observed in Parkinson's disease (PD). However, the possibility that the observed α-synuclein pathology spread is attributable to the passive diffusion of the initial injected α-synuclein strains cannot be excluded. Importantly, most of the studies that have so far addressed the role of extracellular α-synuclein have not employed naturally secreted forms of the protein. It is plausible that deregulation in the normal processing of secreted α-synuclein may aid the formation of "toxic" species and as such it may also be a causative risk factor for PD. In this capacity, elucidation of the underlying mechanisms that regulate the protein-levels of extracellular α-synuclein becomes essential. Such mechanisms could involve its proteolytic clearance from the extracellular milieu.
现已确定,α-突触核蛋白可通过生理途径分泌到细胞外空间。从这个意义上讲,调控该蛋白分泌的机制可能在突触核蛋白病的发生和发展中具有重要作用。分泌增加可能有助于在细胞外形成有毒种子。或者,由于分泌受损导致细胞外α-突触核蛋白的含量减少,可能会增加细胞内负荷并引发细胞内种子形成。一旦释放到细胞外,α-突触核蛋白可通过尚未完全阐明的机制对邻近细胞发挥各种旁分泌作用。已经证明,当在细胞外应用时,α-突触核蛋白可诱导多种神经毒性和炎症反应,并有助于神经元之间的病理传递。然而,分泌的α-突触核蛋白影响其他神经元稳态的确切机制仍未完全清楚。已显示一部分α-突触核蛋白与外泌体的表面和内腔相关联,外泌体可将其转移至周围细胞,并可能引发种子形成。有趣的是,如在帕金森病(PD)中观察到的,外泌体释放增加与溶酶体功能障碍的病理情况有关。然而,不能排除观察到的α-突触核蛋白病理扩散归因于最初注射的α-突触核蛋白菌株的被动扩散的可能性。重要的是,迄今为止,大多数研究细胞外α-突触核蛋白作用的研究并未采用该蛋白的天然分泌形式。正常分泌的α-突触核蛋白加工失调可能有助于形成“有毒”物种,因此它也可能是PD的致病危险因素。在这种情况下,阐明调节细胞外α-突触核蛋白水平的潜在机制变得至关重要。此类机制可能涉及其从细胞外环境中的蛋白水解清除。